.png){kind=icon}
.png){kind=icon}
Return
Complement(ing) thromboinflammation and pathogenesis
.png){kind=icon}
PRE
AI
DOI：10.1016/j.it.2024.04.001.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The persistence or recurrence of symptoms after acute SARS-CoV2 infection, termed 'long COVID', presents a formidable challenge to global healthcare systems. Recent research by Cervia-Hasler and colleagues delves into the intricate immunological landscape in patients with long COVID, demonstrating an interplay between complement and coagulation, driven by antiviral antibodies and tissue damage.
Keywords:
COVID-19